GFAP and neurodegenerative disease: Growing evidence suggests the potential clinical application value of blood GFAP levels in numerous neuroinflammatory and neurodegenerative diseases, as they can be used to detect even subtle injury to the CNS (Abdelhak et al., 2022; Heimfarth et al., 2022).